Artiva Biotherapeutics, Inc. Human Resources Contracts & Agreements
26 Contracts & Agreements
- Bonus & Incentive Agreements (10 contracts)
- Compensation Agreements (2)
- Consulting Agreements (1)
- Employment Agreements (11)
- Retention Agreements (1)
- Separation Agreements (1)
- Non-Employee Director Compensation Policy (Filed With SEC on July 15, 2024)
- Artiva Biotherapeutics, Inc. 2024 Equity Incentive Plan (Filed With SEC on July 15, 2024)
- Employment Offer Letter, dated August 27, 2020, as amended, by and between the Registrant and Jennifer Bush (Filed With SEC on June 28, 2024)
- Employment Offer Letter, dated May 21, 2022, by and between the Registrant and Thorsten Graef, M.D., Ph.D (Filed With SEC on June 28, 2024)
- Executive Employment Agreement, dated December 14, 2020, as amended, by and between the Registrant and Fred Aslan, M.D (Filed With SEC on June 28, 2024)
- Forms of Restricted Stock Unit Grant Notice and Award Agreement under the Artiva Biotherapeutics, Inc. 2024 Equity Incentive Plan (Filed With SEC on June 28, 2024)
- Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the Artiva Biotherapeutics, Inc. 2024 Equity Incentive Plan (Filed With SEC on June 28, 2024)
- Artiva Biotherapeutics, Inc. 2024 Equity Incentive Plan (Filed With SEC on June 28, 2024)
- Forms of Stock Option Grant Notice, Stock Option Grant Notice with Acceleration of Vesting, Option Agreement and Notice of Exercise under the Artiva Biotherapeutics, Inc. 2020... (Filed With SEC on June 28, 2024)
- Artiva Biotherapeutics, Inc. 2020 Equity Incentive Plan, as amended (Filed With SEC on June 28, 2024)
- Employment Offer Letter, dated May 21, 2022, by and between the Registrant and Thorsten Graef, M.D., Ph.D (Filed With SEC on June 6, 2022)
- Consulting Agreement, dated December 15, 2020, by and between the Registrant and Fred Aslan, M.D (Filed With SEC on January 21, 2022)
- Employment Offer Letter, dated December 7, 2021, by and between the Registrant and Christopher P. Horan (Filed With SEC on January 21, 2022)
- Retention Agreement, dated September 21, 2021, by and between the Registrant and Dr. Jason Litten (Filed With SEC on January 21, 2022)
- Separation Agreement, dated October 15, 2021, by and between the Registrant and Thomas J. Farrell (Filed With SEC on December 16, 2021)
- Non-Employee Director Compensation Policy (Filed With SEC on December 16, 2021)
- Forms of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the Artiva Biotherapeutics, Inc. 2022 Equity Incentive Plan (Filed With SEC on December 16, 2021)
- Artiva Biotherapeutics, Inc. 2022 Equity Incentive Plan (Filed With SEC on December 16, 2021)
- Employment Offer Letter, dated March 22, 2021, by and between the Registrant and Michael E. Faerm (Filed With SEC on April 8, 2021)
- Employment Offer Letter, dated August 24, 2020, as amended, by and between the Registrant and Jennifer Bush (Filed With SEC on April 8, 2021)
- Employment Offer Letter, dated August 11, 2019, as amended, by and between the Registrant and Dr. Jason Litten (Filed With SEC on April 8, 2021)
- Employment Offer Letter, dated March 16, 2019, as amended, by and between the Registrant and Dr. Peter Flynn (Filed With SEC on April 8, 2021)
- Executive Employment Agreement, dated March 1, 2019, as amended, by and between the Registrant and Thomas J. Farrell (Filed With SEC on April 8, 2021)
- Executive Employment Agreement, dated December 14, 2020, as amended, by and between the Registrant and Fred Aslan, M.D (Filed With SEC on April 8, 2021)
- Forms of Stock Option Grant Notice, Stock Option Grant Notice with Acceleration of Vesting, Option Agreement and Notice of Exercise under the Artiva Biotherapeutics, Inc. 2020... (Filed With SEC on April 8, 2021)
- Artiva Biotherapeutics, Inc. 2020 Equity Incentive Plan, as amended (Filed With SEC on April 8, 2021)
